After Thursday's planned vote on the American Health Care Act was delayed, President Donald Trump told House Republicans they must vote on and support the measure today, or he will move on to other policy priorities. The Rules Committee is expected to meet this morning to determine terms for debate, with a vote planned for afternoon.
Apicore's abbreviated new drug application for tetrabenazine tablets has been approved by the FDA. The drug, which is indicated for patients with involuntary movements of Huntington's disease, is a generic version of Valeant Pharmaceuticals' Xenazine.
Pfizer CEO Ian Read said national health systems in Europe are taking advantage of innovative drugs developed by US pharmaceutical companies, a contrast with President Donald Trump's past statements that foreign countries get better deals than the US and that Medicare and Medicaid should be able to negotiate drug prices.
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.
Contact PCMA Charles Cote
Vice President, Strategic Communications